Posted by SLS on January 16, 2008, at 5:54:44
In reply to Re: New: Board Neurotransmitters, posted by Dr. Bob on January 16, 2008, at 0:58:36
> > What a tough call it will be to try to separate posting on one board versus the other.
>
> I agree, and expect it'll evolve with time.
>
> > I think the "Medication" board should focus on clinical issues (specific therapeutic interventions).
> >
> > A "Neuroscience" board might better focus on pure research and theory without focusing on therapeutics.
>
> That would be one way to do it, but clinical issues can be "advanced", too.
>
> I'm open to changing the name, though. Any other suggestions?
------------------------------------------------
Hi doctor.I don't always like change. I have, for the most part, come to agree with a great many of your innovations. However, I think separating the "Medication" into simple versus complex drug regimes is both arbitrary and clinically irrelevant. In fact, I would guess that there would be fewer novel ideas synthesized aimed at getting people well if psychopharmacological ideas could not be shared in one place.
I haven't done a study, but it seems to me that the majority of people on the Psycho-Babble "Medication" board are treatment resistant. This will most likely indicate combination therapy. Besides not understanding the technical verbiage to appear on the "Neurotransmitter" board - which is really a combination treatment board - a treatment-resistant person new to the study of their own illness might be unable to look for clinical information would benefit them.
How many people take one antidepressant plus lithium? This is combination treatment and would thus be directed to an unnecessarily sophisticated correspondence. What about adding bethanecol to a TCA to treat delayed micturition. How do you foster continuity of threads involving therapeutics if its definition is determined by how many drugs one takes?
Do we still have a "Newbies" board? Let me check. Ah yes. What is this board supposed to be for? I like to think of it as an introduction to the basic operation and theme of the boards and the first questions one has as to where to initially look for information.
I think it is counterproductive to separate out posts such that people can no longer easily follow another's treatment history because the number of drugs they try constantly causes them to flip from one board or another.
"Medication" could be devoted to the clinical treatment of individuals, including relevant medical and neuroscience information.
A "Neuroscience" board might better serve conversations regarding pure science and theory such that it applies to psychiatry and people in general. Issues to be included might be things like clinical trials, receptor-ligand dynamics, upstream and downstream events, second messenger cascade events, gene regulation, brain circuitry, pathological morphology and processes, neuroendocrine function, etc.
I think all the people who are looking desperately only for information that might get them well using pharmacological intervention should interact on one board, regardless of the number of agents used or how aggressive the treatment.
The separation in theme that is currently being practiced with the appearance of the new "Neurotransmitter" board has the potential to deter education and mutual support.
- Scott
poster:SLS
thread:806657
URL: http://www.dr-bob.org/babble/admin/20071106/msgs/806931.html